CONTEXT: The incidence of pediatric type 2 diabetes (T2D) is rising, with unclear effects on the cardiovascular system. Cardiopulmonary fitness, a marker of morbidity and mortality, is abnormal in adults with T2D, yet the mechanisms are incompletely understood. OBJECTIVE: We hypothesized that cardiopulmonary fitness would be reduced in youth with T2D in association with insulin resistance (IR) and cardiovascular dysfunction. DESIGN, SETTING, AND PARTICIPANTS: We conducted a cross-sectional study at an academic hospital that included 14 adolescents (age range, 12-19 yr) with T2D, 13 equally obese adolescents and 12 lean adolescents similar in age, pubertal stage, and activity level. MAIN OUTCOME MEASURES: Cardiopulmonary fitness was measured by peak oxygen consumption (VO(2)peak) and oxygen uptake kinetics (VO(2)kinetics), IR by hyperinsulinemic clamp, cardiac function by echocardiography, vascular function by venous occlusion plethysmography, body composition by dual-energy x-ray absorptiometry, intramyocellular lipid by magnetic resonance spectroscopy, and inflammation by serum markers. RESULTS: Adolescents with T2D had significantly decreased VO(2)peak and insulin sensitivity, and increased soleus intramyocellular lipid, C-reactive protein, and IL-6 compared to obese or lean adolescents. Adolescents with T2D also had significantly prolonged VO(2)kinetics, decreased work rate, vascular reactivity, and adiponectin, and increased left ventricular mass and fatty acids compared to lean adolescents. In multivariate linear regression analysis, IR primarily, and fasting free fatty acids and forearm blood flow secondarily, were significant independent predictors of VO(2)peak. CONCLUSIONS: Given the strong relationship between decreased cardiopulmonary fitness and increased mortality, these findings in children are especially concerning and represent early signs of impaired cardiac function.
CONTEXT: The incidence of pediatric type 2 diabetes (T2D) is rising, with unclear effects on the cardiovascular system. Cardiopulmonary fitness, a marker of morbidity and mortality, is abnormal in adults with T2D, yet the mechanisms are incompletely understood. OBJECTIVE: We hypothesized that cardiopulmonary fitness would be reduced in youth with T2D in association with insulin resistance (IR) and cardiovascular dysfunction. DESIGN, SETTING, AND PARTICIPANTS: We conducted a cross-sectional study at an academic hospital that included 14 adolescents (age range, 12-19 yr) with T2D, 13 equally obese adolescents and 12 lean adolescents similar in age, pubertal stage, and activity level. MAIN OUTCOME MEASURES: Cardiopulmonary fitness was measured by peak oxygen consumption (VO(2)peak) and oxygen uptake kinetics (VO(2)kinetics), IR by hyperinsulinemic clamp, cardiac function by echocardiography, vascular function by venous occlusion plethysmography, body composition by dual-energy x-ray absorptiometry, intramyocellular lipid by magnetic resonance spectroscopy, and inflammation by serum markers. RESULTS: Adolescents with T2D had significantly decreased VO(2)peak and insulin sensitivity, and increased soleus intramyocellular lipid, C-reactive protein, and IL-6 compared to obese or lean adolescents. Adolescents with T2D also had significantly prolonged VO(2)kinetics, decreased work rate, vascular reactivity, and adiponectin, and increased left ventricular mass and fatty acids compared to lean adolescents. In multivariate linear regression analysis, IR primarily, and fasting free fatty acids and forearm blood flow secondarily, were significant independent predictors of VO(2)peak. CONCLUSIONS: Given the strong relationship between decreased cardiopulmonary fitness and increased mortality, these findings in children are especially concerning and represent early signs of impaired cardiac function.
Authors: Claus Thamer; Jürgen Machann; Oliver Bachmann; Michael Haap; Dominik Dahl; Beate Wietek; Otto Tschritter; Andreas Niess; Klaus Brechtel; Andreas Fritsche; Claus Claussen; Stephan Jacob; Fritz Schick; Hans-Ulrich Häring; Michael Stumvoll Journal: J Clin Endocrinol Metab Date: 2003-04 Impact factor: 5.958
Authors: Wei Shen; Xiangling Mao; Carla Wolper; Stanley Heshka; Stephen Dashnaw; Joy Hirsch; Steven B Heymsfield; Dikoma C Shungu Journal: NMR Biomed Date: 2008-06 Impact factor: 4.044
Authors: E J Mayer-Davis; M Z Vitolins; S L Carmichael; S Hemphill; G Tsaroucha; J Rushing; S Levin Journal: Ann Epidemiol Date: 1999-07 Impact factor: 3.797
Authors: Sarah J Lessard; Donato A Rivas; Erin J Stephenson; Ben B Yaspelkis; Lauren G Koch; Steven L Britton; John A Hawley Journal: Am J Physiol Regul Integr Comp Physiol Date: 2010-11-03 Impact factor: 3.619
Authors: Melanie Cree-Green; Bryan C Bergman; Eda Cengiz; Larry A Fox; Tamara S Hannon; Kellee Miller; Brandon Nathan; Laura Pyle; Darcy Kahn; Michael Tansey; Eileen Tichy; Eva Tsalikian; Ingrid Libman; Kristen J Nadeau Journal: J Clin Endocrinol Metab Date: 2019-08-01 Impact factor: 5.958
Authors: Lorraine Levitt Katz; Samuel S Gidding; Fida Bacha; Kathryn Hirst; Siripoom McKay; Laura Pyle; Joao A C Lima Journal: Pediatr Diabetes Date: 2014-01-22 Impact factor: 4.866
Authors: Judith G Regensteiner; Timothy A Bauer; Amy G Huebschmann; Leah Herlache; Howard D Weinberger; Eugene E Wolfel; Jane E B Reusch Journal: Med Sci Sports Exerc Date: 2015-01 Impact factor: 5.411